{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:56:51Z","timestamp":1784955411515,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":130,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Servier, the Netherlands"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.ijcard.2020.03.001","type":"journal-article","created":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T23:58:56Z","timestamp":1583711936000},"page":"60-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Atrial fibrillation in chronic heart failure patients with reduced ejection fraction: The CHECK-HF registry"],"prefix":"10.1016","volume":"308","author":[{"given":"Jesse F.","family":"Veenis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Brunner-La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard C.M.","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.J.","family":"Smeele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00ebmi T.A.E.","family":"Wouters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul H.M.","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"Rademaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.W.","family":"Hemels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Rienstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arno W.","family":"Hoes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper J.","family":"Brugts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.03.001_bb0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial fibrillation in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"5","author":"Sartipy","year":"2017","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0010","doi-asserted-by":"crossref","first-page":"2D","DOI":"10.1016\/S0002-9149(02)03373-8","article-title":"Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy","volume":"91","author":"Maisel","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0015","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/eurjhf\/hfr066","article-title":"Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction","volume":"13","author":"Linssen","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0020","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.hlc.2017.05.117","article-title":"Atrial fibrillation and heart failure - cause or effect?","volume":"26","author":"Prabhu","year":"2017","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0025","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.amjcard.2017.02.050","article-title":"Effect of atrial fibrillation on mortality, stroke risk, and quality-of-life scores in patients with heart failure (from the outcomes registry for better informed treatment of atrial fibrillation [ORBIT-AF])","volume":"119","author":"Cherian","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0030","doi-asserted-by":"crossref","first-page":"744","DOI":"10.5603\/CJ.a2018.0074","article-title":"The effect of beta-blockers on mortality in patients with heart failure and atrial fibrillation: a meta-analysis of observational cohort and randomized controlled studies","volume":"26","author":"Ma","year":"2019","journal-title":"Cardiol. J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0035","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0045","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s12471-018-1103-7","article-title":"Real-world heart failure management in 10,910 patients with chronic heart failure in the Netherlands: design and rationale of the Chronic Heart failure ESC guideline-based Cardiology practice Quality project (CHECK-HF) registry","volume":"26","author":"Brugts","year":"2018","journal-title":"Neth. Hear. J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0050","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0055","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jchf.2018.10.010","article-title":"Contemporary drug treatment of chronic heart failure with reduced ejection fraction: the CHECK-HF registry","volume":"7","author":"Brunner-La Rocca","year":"2019","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0060","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ahj.2009.03.010","article-title":"Influence of age on the management of heart failure: findings from Get With the Guidelines-Heart Failure (GWTG-HF)","volume":"157","author":"Forman","year":"2009","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0065","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0070","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/clc.22725","article-title":"Heart rate and outcome in heart failure with reduced ejection fraction: differences between atrial fibrillation and sinus rhythm-a CIBIS II analysis","volume":"40","author":"Mulder","year":"2017","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0075","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/CIRCHEARTFAILURE.115.002285","article-title":"Prognostic significance of resting heart rate and use of beta-blockers in atrial fibrillation and sinus rhythm in patients with heart failure and reduced ejection fraction: findings from the Swedish Heart Failure Registry","volume":"8","author":"Li","year":"2015","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0080","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/ejhf.346","article-title":"Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta-analysis","volume":"17","author":"Simpson","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0085","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2124","article-title":"Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation","volume":"16","author":"Rudolph","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0090","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/hrt.63.3.157","article-title":"What is meant by a \u201ccontrolled\u201d ventricular rate in atrial fibrillation?","volume":"63","author":"Rawles","year":"1990","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0095","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchf.2012.09.002","article-title":"Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis","volume":"1","author":"Rienstra","year":"2013","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0100","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1016\/j.jacc.2017.04.001","article-title":"Heart rate and rhythm and the benefit of beta-blockers in patients with heart failure","volume":"69","author":"Kotecha","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijcard.2018.08.012","article-title":"Dose-dependent efficacy of beta-blocker in patients with chronic heart failure and atrial fibrillation","volume":"273","author":"Campodonico","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0110","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1253\/circj.CJ-15-0783","article-title":"Prognostic impact of new-onset atrial fibrillation in patients with chronic heart failure - a report from the CHART-2 study","volume":"80","author":"Yamauchi","year":"2016","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0120","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jchf.2018.05.005","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: the TOPCAT trial","volume":"6","author":"Cikes","year":"2018","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0125","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jacc.2011.11.063","article-title":"Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study","volume":"59","author":"Swedberg","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0130","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1007\/s00392-014-0743-x","article-title":"Characteristics, management modalities and outcome in chronic systolic heart failure patients treated in tertiary care centers: results from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry","volume":"103","author":"von Scheidt","year":"2014","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0135","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/jce.12535","article-title":"Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials","volume":"25","author":"Cadrin-Tourigny","year":"2014","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0140","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.hrthm.2004.09.028","article-title":"Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study","volume":"2","author":"Hagens","year":"2005","journal-title":"Heart Rhythm."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0145","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehi687","article-title":"Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial","volume":"27","author":"Ahmed","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0150","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","author":"Digitalis","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0155","doi-asserted-by":"crossref","first-page":"333","DOI":"10.5603\/CJ.a2016.0016","article-title":"Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation","volume":"23","author":"Qureshi","year":"2016","journal-title":"Cardiol. J."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0160","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.clinthera.2014.07.015","article-title":"The impact of heart failure and left ventricular dysfunction in predicting stroke, thromboembolism, and mortality in atrial fibrillation patients: a systematic review","volume":"36","author":"Agarwal","year":"2014","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0165","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jacc.2009.01.055","article-title":"Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation","volume":"53","author":"Nieuwlaat","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/clc.23142","article-title":"Anticoagulation in patients with atrial fibrillation and heart failure: insights from the NCDR PINNACLE-AF registry","volume":"42","author":"Contreras","year":"2019","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jchf.2016.07.012","article-title":"Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis","volume":"4","author":"Savarese","year":"2016","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2020.03.001_bb0180","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/ejhf.343","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) in patients with concomitant atrial fibrillation and heart failure: a systemic review and meta-analysis of randomized trials","volume":"17","author":"Xiong","year":"2015","journal-title":"Eur. J. Heart Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320301558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527320301558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:45:48Z","timestamp":1759092348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527320301558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":36,"alternative-id":["S0167527320301558"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.001","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation in chronic heart failure patients with reduced ejection fraction: The CHECK-HF registry","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}